OR Royalties (OR) Expected to Announce Earnings on Wednesday

OR Royalties (NYSE:OR) is expected to be posting its Q4 2025 results before the market opens on Wednesday, February 18th. Analysts expect OR Royalties to post earnings of $0.31 per share for the quarter. Individuals are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Thursday, February 19, 2026 at 10:00 AM ET.

OR Royalties Stock Performance

Shares of OR Royalties stock opened at $42.98 on Wednesday. OR Royalties has a twelve month low of $17.55 and a twelve month high of $47.75. The firm has a market cap of $8.04 billion, a P/E ratio of 54.41 and a beta of 0.76. The firm’s 50-day simple moving average is $38.74 and its 200-day simple moving average is $35.50.

Hedge Funds Weigh In On OR Royalties

Institutional investors have recently made changes to their positions in the stock. Goldman Sachs Group Inc. increased its position in shares of OR Royalties by 152.4% during the first quarter. Goldman Sachs Group Inc. now owns 1,256,583 shares of the basic materials company’s stock worth $26,539,000 after acquiring an additional 758,815 shares in the last quarter. Invesco Ltd. increased its stake in shares of OR Royalties by 85.3% during the 3rd quarter. Invesco Ltd. now owns 1,543,366 shares of the basic materials company’s stock worth $61,858,000 after purchasing an additional 710,654 shares during the last quarter. Tidal Investments LLC boosted its position in OR Royalties by 25.4% during the third quarter. Tidal Investments LLC now owns 2,347,760 shares of the basic materials company’s stock worth $94,098,000 after purchasing an additional 474,840 shares during the period. Jane Street Group LLC lifted its position in shares of OR Royalties by 334.1% during the second quarter. Jane Street Group LLC now owns 470,493 shares of the basic materials company’s stock worth $12,096,000 after acquiring an additional 362,098 shares in the last quarter. Finally, Qube Research & Technologies Ltd lifted its holdings in OR Royalties by 45.7% during the 2nd quarter. Qube Research & Technologies Ltd now owns 827,538 shares of the basic materials company’s stock worth $21,276,000 after purchasing an additional 259,370 shares in the last quarter. Institutional investors and hedge funds own 68.52% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently issued reports on the stock. Canadian Imperial Bank of Commerce reiterated an “outperform” rating on shares of OR Royalties in a research report on Wednesday, February 4th. Wall Street Zen upgraded OR Royalties from a “buy” rating to a “strong-buy” rating in a research report on Monday, January 19th. Canaccord Genuity Group raised shares of OR Royalties from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, October 22nd. Weiss Ratings reissued a “buy (b)” rating on shares of OR Royalties in a research note on Monday, December 29th. Finally, Scotiabank boosted their price objective on shares of OR Royalties from $41.00 to $51.00 and gave the company a “sector perform” rating in a research report on Monday, January 26th. Two equities research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $38.25.

OR Royalties Company Profile

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.